Search

for
Search:

Research

5 / 1000+ results

research Hair restoration; clinical study to evaluate the efficacy of a combined treatment between specific meso hair cocktail class III device and microneedling device in different baldness patterns

November 2017 in “Journal of cosmetology & trichology”

The combined treatment of a specific hair cocktail and microneedling device effectively restores hair in different baldness patterns.

research Microstrip technique in follicular unit extraction

1 citations , May 2015 in “Dermatologic Therapy”

The microstrip technique for hair transplantation is effective and discreet for patients needing fewer than 1500 grafts.

research Cosmetic devices based on active transdermal technologies

19 citations , September 2015 in “Therapeutic Delivery”

This review discusses the application of active transdermal technologies in cosmetic devices for skin restoration and enhancement, reporting no new clinical results.

research Follicular Unit Excision in Patients of African Descent: A Skin-Responsive Technique

7 citations , August 2023 in “Dermatologic Surgery”

In this study, researchers reported that a new skin-responsive FU excision device consistently succeeded in all patients of African descent, showing a mean graft transection rate of less than 10%, with skin thickness and firmness identified as major factors affecting graft attrition rate.

research STIMULATION OF HAIR REGROWTH USING LOW LEVEL LASER TREATMENT IN A RAT MODEL OF ALOPECIA

January 2013

This study found that in a rat model of alopecia, combining low-level laser therapy with Neoptide treatment resulted in better hair regrowth compared to either treatment used alone.

View more "class iii device" in research →

Community Join

3 / 240 results

community Pelage Pharmaceuticals’ PP405 and its Impact on Follicular Regeneration to be Presented at the American Academy of Dermatology (AAD) Annual Meeting 2026

122 upvotes 6 months ago

PP405 shows promise in regenerating hair by activating dormant follicles. Other treatments like VDPHL01 and Breezula are also advancing, providing new hope for hair loss solutions.

community HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

110 upvotes 2 years ago

Chime Biologics and Hope Medicine are speeding up the launch of a first-in-class antibody drug, HMI-115, for endometriosis and androgenic alopecia. The treatment involves a series of subcutaneous injections, has shown promising results in phase 1, and continues to promote hair regrowth even after the treatment is stopped.

community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

133 upvotes 2 years ago

The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.

View more "class iii device" in community →

Learn

— no results

Try a deeper search in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →